NCT03480971 2024-11-20
Treatment of Radiation and Cisplatin Induced Toxicities with Tempol
Matrix Biomed, Inc.
Phase 2 Recruiting
Clinical Trials
6 trialsNCT05491928 2022-09-01
Treatment of Metastatic Cancer in Terminally Diagnosed Patients
Matrix Biomed, Inc.
Available
NCT01324141 2021-11-23
Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer
National Institutes of Health Clinical Center (CC)
Phase 1 Terminated
NCT04876755 2021-05-06
MBM-02 (Tempol) for the Treatment of Biochemical Recurrent Prostate Cancer
Matrix Biomed, Inc.
Phase 2 Unknown
NCT04337099 2021-05-05
A Single Patient Compassionate Use of MBM-02 (Tempol) for the Treatment of Prostate Cancer
Matrix Biomed, Inc.
Available
NCT04874506 2021-05-05
MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM)
Matrix Biomed, Inc.
Phase 2 Unknown